Clinical Trial Update: Effect of Lecithin-based Curcuma and Boswellia on Post-acute COVID-19 IBS [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of a lecithin-based curcuma (turmeric) formulation in combination with Boswellia on post-acute COVID-19 syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Boswellia serrata extract (Boswellia serrata extract)
• Curcuma longa lecithin formulation (Curcuma longa (turmeric) extract with lecithin)

Snippet

Sponsor: Azienda di Servizi alla Persona di Pavia | Conditions: Post-Acute COVID-19 Syndrome, Irritable Bowel Syndrome | NA | Status: COMPLETED